NASDAQ$TRUP
Trupanion Inc · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Trupanion's financial performance in Q1 2023, marked by strong revenue growth amidst veterinary inflation, which pressured margins.
Trupanion's Q1 2023 saw a 24% increase in total revenue to $256.3 million, driven by strong demand despite veterinary inflation increasing 15% year-over-year. The company reported a net loss of $(24.8) million, or $(0.60) per share, which included $8.6 million of non-recurring expenses, and an adjusted EBITDA of $(4.9) million. Total enrolled pets reached 1,616,865, a 28% increase year-over-year.
- Total revenue increased by 24% to $256.3 million compared to Q1 2022.
- Total enrolled pets grew by 28% to 1,616,865 as of March 31, 2023.
- Subscription business revenue increased by 18% to $165.2 million compared to Q1 2022.
- Net loss was $(24.8) million, or $(0.60) per share, including $8.6 million in non-recurring expenses.
Headline financials
Revenue & EPS history
Trupanion · Revenue · Quarterly
$256M
Revenue by segment
Trupanion · $246M total across 2 segments · Q4 2022
- Subscription business$159M+18.2%64.5%
- Other business$87.4M+45.1%35.5%
Forward guidance
Trupanion's management is focused on executing the second half of their 60-month plan and achieving their margin targets, while navigating veterinary inflation.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2023
-0.8%
Avg return
Earnings day
+0.1%
Avg return
5 days after
+2.0%
Avg return
30 days after
46%
19 / 41 earnings
Positive
+28.3%
Q2 2020
Best reaction
-31.3%
Q4 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.5% | +3.9% | -9.1% | |
| Q4 2025 | -13.0% | -10.3% | -23.0% | |
| Q3 2025 | -8.4% | -7.6% | -12.3% | |
| Q1 2025 | +23.2% | +22.4% | +29.5% | |
| Q4 2024 | -25.5% | -28.2% | -22.1% | |
| Q3 2024 | +2.9% | -6.0% | +0.1% | |
| Q2 2024 | +13.8% | +21.5% | +29.9% | |
| Q1 2024 | -14.9% | +9.6% | +28.1% | |
| Q4 2023 | -31.3% | -26.8% | -18.6% | |
| Q3 2023 | +27.8% | +11.7% | +43.5% | |
| Q2 2023 | +7.8% | +15.2% | +2.3% | |
| Q1 2023 | -17.5% | -30.8% | -34.2% | |
| Q4 2022 | -0.1% | -3.1% | -7.6% | |
| Q3 2022 | +2.1% | +10.1% | +21.6% | |
| Q2 2022 | +3.0% | +13.2% | +3.7% | |
| Q1 2022 | -7.6% | -0.9% | +0.1% | |
| Q4 2021 | -19.0% | -17.1% | -3.4% | |
| Q3 2021 | +17.0% | +20.8% | +9.2% | |
| Q2 2021 | -13.5% | -13.4% | -20.9% | |
| Q1 2021 | -3.3% | -8.6% | +7.5% | |
| Q4 2020 | -11.2% | -9.9% | -22.2% | |
| Q3 2020 | +0.1% | +17.6% | +37.1% | |
| Q2 2020 | +28.3% | +39.0% | +31.7% | |
| Q1 2020 | -16.1% | -13.9% | -10.3% | |
| Q4 2019 | -17.4% | -9.3% | -22.6% | |
| Q3 2019 | +23.4% | +31.2% | +35.8% | |
| Q2 2019 | -2.6% | -4.8% | -25.9% | |
| Q1 2019 | -1.4% | -1.9% | -11.6% | |
| Q4 2018 | -4.8% | +0.9% | +6.0% | |
| Q3 2018 | +3.0% | -7.7% | -1.3% | |
| Q2 2018 | -3.6% | -7.5% | -7.4% | |
| Q1 2018 | +5.4% | +1.4% | +20.9% | |
| Q4 2017 | -0.0% | -9.2% | +9.5% | |
| Q3 2017 | +13.1% | +11.6% | +3.2% | |
| Q2 2017 | +0.2% | -2.8% | -8.1% | |
| Q1 2017 | +0.9% | +4.7% | +29.0% | |
| Q4 2016 | +3.0% | -2.2% | -10.5% | |
| Q3 2016 | -7.7% | -7.0% | +1.9% | |
| Q2 2016 | -0.3% | -0.6% | -0.5% | |
| Q1 2016 | +13.0% | — | — | |
| Q2 2014 | -1.3% | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro